Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Feb
23
2024
Ninth Circuit Provides Further Guidance on Trademark Lawsuits Involving “Expressive Works” Proskauer Rose LLP
Feb
22
2024
Global Patenting Trends: WIPO Reports a Record Number of Patent Filings ArentFox Schiff LLP
Feb
22
2024
PTO on AI Inventorship: Will the Real Natural Human Inventors Please Stand Up? McDermott Will & Emery
Feb
22
2024
Uncle Sam Can March In: Government Licenses Under Bayh-Dole Aren’t Subject to “Strict Timing Requirements” McDermott Will & Emery
Feb
22
2024
No Home Away From Home: Federal Circuit Confirms PTO Domicile Requirements McDermott Will & Emery
Feb
22
2024
Copyrightability? Think Outside the Checkbox McDermott Will & Emery
Feb
22
2024
Trademark Trial & Appeal Board Gets a DuPont 101 Lesson McDermott Will & Emery
Feb
22
2024
Top Legal Considerations for the GCs and CFOs in the Life Sciences Industry in 2024 ArentFox Schiff LLP
Feb
21
2024
A Brief Explanation of the USPTO’s Useful New AI-Assisted Invention Guidance Hunton Andrews Kurth
Feb
21
2024
AI-Assisted Inventions: Is There a Duty to Disclose the Use of AI? Sheppard, Mullin, Richter & Hampton LLP
Feb
20
2024
Gold Dome Report – Legislative Day 23 (2024) Nelson Mullins
Feb
20
2024
Chinese Copyright Registrations Up 40% in 2023 Schwegman, Lundberg & Woessner, P.A.
Feb
20
2024
Design Patent vs. Trade Dress: Strategic Considerations for Protecting Product Designs Polsinelli PC
Feb
19
2024
USPTO Releases Guidance on Rule 132 Declarations Foley & Lardner LLP
Feb
19
2024
Which Significant USPTO Fee Increases Might We See in 2025? Foley & Lardner LLP
Feb
16
2024
Gold Dome Report – Legislative Day 22 (2024) Nelson Mullins
Feb
16
2024
DOJ and SEC Officials Issue Harsh Warnings Concerning the Misuse of AI Sheppard, Mullin, Richter & Hampton LLP
Feb
15
2024
Gold Dome Report – Legislative Day 21 (2024) Nelson Mullins
Feb
15
2024
China Newsletter | Q3 2023/Issue No. 58 Greenberg Traurig, LLP
Feb
15
2024
USPTO Warns Against Blind Reliance on Artificial Intelligence Foley & Lardner LLP
Feb
15
2024
5 Trends to Watch: 2024 Robotics Greenberg Traurig, LLP
Feb
15
2024
Memo for Use of AI During Practice Issued by USPTO Robinson & Cole LLP
Feb
15
2024
AI-Assisted Innovation: Navigating the USPTO's Latest Guidelines Blank Rome LLP
Feb
15
2024
Lost Connection: Preliminary Injunction Against Unreleased Product Is a No-Go McDermott Will & Emery
Feb
15
2024
No Fair Use for Photo Used Without Required Attribution McDermott Will & Emery
Feb
15
2024
Sliced and Diced: Operating Manuals Are Printed Publications McDermott Will & Emery
Feb
15
2024
Even a Non-Explicit Claim Construction Can Be Erroneous McDermott Will & Emery
Feb
14
2024
Federal Circuit Rules on Inventor-as-Lexicographer Definitions and the Proper Scope of Reply and Sur-Reply Briefing Following Patent Owner Responses to IPR Institution Decisions Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins